Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 360Neoplasms 254Prostatic Neoplasms 206Colorectal Neoplasms 157Lung Neoplasms 136Carcinoma, Non-Small-Cell Lung 112Leukemia, Myeloid, Acute 109Pancreatic Neoplasms 99Multiple Myeloma 93Glioblastoma 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Brain Neoplasms 78Head and Neck Neoplasms 77Carcinoma, Hepatocellular 70Melanoma 68Squamous Cell Carcinoma of Head and Neck 66Uterine Cervical Neoplasms 61Ovarian Neoplasms 61Neoplasm Metastasis 59Rectal Neoplasms 53Hematologic Neoplasms 53Glioma 53Stomach Neoplasms 50Recurrence 49Carcinoma, Renal Cell 49Myelodysplastic Syndromes 47Sarcoma 46Motor Activity 46Triple Negative Breast Neoplasms 44Esophageal Neoplasms 44

Interventions

Tobacco Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Smoking Reduction × 30 days × Clear all
NCT04620915 2026-05-08

Construal Level as a Novel Pathway for Affect Regulation and Cancer Control

University of Oregon

Phase NA Completed
300 enrolled

Smoking Reduction, Neoplasms, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡